TKNO
Alpha Teknova, Inc. NASDAQ Listed Jun 25, 2021$3.64
After hrs
$3.64
+0.00%
Mkt Cap $195.1M
52w Low $1.91
31.1% of range
52w High $7.48
50d MA $2.85
200d MA $3.98
P/E (TTM)
-10.6x
EV/EBITDA
-20.9x
P/B
2.6x
Debt/Equity
0.2x
ROE
-25.1%
P/FCF
-22.0x
RSI (14)
—
ATR (14)
—
Beta
0.33
50d MA
$2.85
200d MA
$3.98
Avg Volume
203.9K
About
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellula…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | -0.09 | -0.09 | +0.0% | 2.28 | +0.0% | +13.2% | +4.4% | +2.6% | +2.6% | -3.1% | — |
| Nov 6, 2025 | AMC | -0.09 | -0.08 | +14.7% | 4.81 | -6.2% | -2.1% | -4.2% | +1.9% | -7.3% | -7.9% | — |
| Aug 7, 2025 | AMC | -0.10 | -0.07 | +30.3% | 4.34 | +26.3% | -2.5% | +1.6% | +10.1% | +12.4% | +10.6% | — |
| May 8, 2025 | AMC | -0.11 | -0.09 | +18.2% | 6.37 | +14.6% | +9.3% | +10.8% | +5.8% | +2.4% | +2.2% | — |
| Mar 4, 2025 | AMC | -0.12 | -0.11 | +8.3% | 6.04 | +9.6% | -1.2% | -5.1% | +0.8% | -8.6% | -10.9% | — |
| Nov 7, 2024 | AMC | -0.11 | -0.15 | -36.4% | 6.89 | +8.7% | +3.9% | +9.7% | -7.4% | -9.3% | -4.8% | — |
| Aug 13, 2024 | AMC | -0.16 | -0.13 | +18.8% | 3.97 | +1.8% | -6.5% | +1.3% | +24.7% | +22.7% | +24.4% | — |
| May 13, 2024 | AMC | -0.24 | -0.20 | +16.7% | 1.74 | +4.0% | +12.1% | +8.0% | +9.2% | +2.9% | +2.9% | — |
| Mar 11, 2024 | AMC | -0.23 | -0.22 | +4.3% | 3.02 | -5.3% | -5.6% | -5.3% | -1.7% | -5.6% | -5.6% | — |
| Nov 9, 2023 | AMC | -0.28 | -0.34 | -21.4% | 2.01 | -1.5% | -3.0% | +1.0% | +4.0% | +6.5% | +3.0% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10 | Stephens & Co. | Maintains | Overweight → Overweight | — | $1.23 | $1.25 | +1.6% | -0.8% | +0.8% | +4.1% | +4.1% | +9.8% |
| May 14 | Stephens & Co. | Maintains | Overweight → Overweight | — | $1.74 | $1.81 | +4.0% | +12.1% | +8.0% | +9.2% | +2.9% | +2.9% |
| Mar 12 | BTIG | Downgrade | Buy → Neutral | — | $3.02 | $2.86 | -5.3% | -5.6% | -5.3% | -1.7% | -5.6% | -5.6% |
| Aug 11 | Stephens & Co. | Maintains | Overweight → Overweight | — | $5.79 | $5.53 | -4.5% | -19.3% | -13.5% | -10.6% | -6.2% | -16.8% |
| Mar 16 | Stephens & Co. | Maintains | Overweight → Overweight | — | $14.84 | $14.61 | -1.5% | +1.1% | -3.9% | +14.2% | -1.4% | -1.5% |
| Jul 20 | BTIG | Maintains | Buy → Buy | — | $18.06 | $18.99 | +5.1% | -2.5% | -1.7% | -0.7% | -0.9% | -3.3% |
| Jul 20 | Cowen & Co. | Maintains | Outperform → Outperform | — | $18.06 | $18.99 | +5.1% | -2.5% | -1.7% | -0.7% | -0.9% | -3.3% |
| Jul 20 | Stephens & Co. | Maintains | Overweight → Overweight | — | $18.06 | $18.99 | +5.1% | -2.5% | -1.7% | -0.7% | -0.9% | -3.3% |
Recent Filings
8-K · 2.02
!! High
Alpha Teknova, Inc. -- 8-K 2.02: Earnings Results
Alpha Teknova's quarterly earnings results were disclosed via press release, providing investors with updated operational and financial performance metrics for evaluating the company's recent business trajectory.
May 6
8-K
Alpha Teknova, Inc. -- 8-K Filing
Alpha Teknova reported 2025 revenue of $40.5 million, up 7% year-over-year, and guided 2026 revenue to $42-44 million, indicating modest continued growth expectations.
Feb 26
Data updated apr 27, 2026 4:54am
· Source: massive.com